Literature DB >> 23319570

Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.

Daisuke Kurotaki1, Naoki Osato, Akira Nishiyama, Michio Yamamoto, Tatsuma Ban, Hideaki Sato, Jun Nakabayashi, Marina Umehara, Noriko Miyake, Naomichi Matsumoto, Masatoshi Nakazawa, Keiko Ozato, Tomohiko Tamura.   

Abstract

Monocytes regulate host defenses, inflammation, and tissue homeostasis. The transcription factor interferon regulatory factor-8 (IRF8) stimulates monocyte/macrophage differentiation, yet genome-wide understanding of the differentiation program initiated by IRF8 is lacking. By combining chromatin immunoprecipitation sequencing with gene expression profiling, we show that during IRF8-dependent monocyte differentiation, IRF8 binding occurs at both promoter-proximal and promotor-distal regions together with the transcription factor PU.1 and is associated with gene induction. Many of the promoter-distal IRF8 binding sites show an increase in histone H3 lysine 4 monomethylation, a signature for enhancers. However, about half the IRF8-induced genes were not bound by IRF8, suggesting the involvement of downstream transcription factors. Analysis of DNA motifs in cis-regulatory elements of these indirect IRF8 target genes predicted that Krüppel-like factor-4 (KLF4)-essential for Ly6C(+) monocyte development-is one such factor. Indeed, monocyte development in Irf8(-/-) mice is as defective as that in Klf4(-/-) chimeric mice. Moreover, Irf8(-/-) monocyte-dendritic cell progenitors do not express Klf4 messenger RNA. Introduction of KLF4 into an Irf8(-/-) myeloid progenitor cell line induced a subset of IRF8 target genes and caused partial monocyte differentiation. Taken together, our present results uncover genome-wide behavior of IRF8 and identify an IRF8-KLF4 axis that operates during monocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23319570      PMCID: PMC3591803          DOI: 10.1182/blood-2012-06-437863

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.

Authors:  T Tamura; T Nagamura-Inoue; Z Shmeltzer; T Kuwata; K Ozato
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

2.  Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Keiko Ozato
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

3.  Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response.

Authors:  Cord Sunderkötter; Tatjana Nikolic; Marilyn J Dillon; Nico Van Rooijen; Martin Stehling; Douglas A Drevets; Pieter J M Leenen
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

4.  The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.

Authors:  H Q Nguyen; B Hoffman-Liebermann; D A Liebermann
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

Review 5.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Authors:  Tomohiko Tamura; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

6.  Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein.

Authors:  M Scheller; J Foerster; C M Heyworth; J F Waring; J Löhler; G L Gilmore; R K Shadduck; T M Dexter; I Horak
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

7.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

8.  Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice.

Authors:  Yvonne Döring; Oliver Soehnlein; Maik Drechsler; Erdenechimeg Shagdarsuren; Sweena M Chaudhari; Svenja Meiler; Helene Hartwig; Mihail Hristov; Rory R Koenen; Thomas Hieronymus; Martin Zenke; Christian Weber; Alma Zernecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-03       Impact factor: 8.311

9.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

10.  ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Authors:  Giovanna Schiavoni; Fabrizio Mattei; Paola Sestili; Paola Borghi; Massimo Venditti; Herbert C Morse; Filippo Belardelli; Lucia Gabriele
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  88 in total

Review 1.  Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.

Authors:  Shuhei Asada; Toshio Kitamura
Journal:  Int J Hematol       Date:  2018-12-05       Impact factor: 2.490

2.  Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells.

Authors:  Haruka Sasaki; Daisuke Kurotaki; Naoki Osato; Hideaki Sato; Izumi Sasaki; Shin-ichi Koizumi; Hongsheng Wang; Chika Kaneda; Akira Nishiyama; Tsuneyasu Kaisho; Hiroyuki Aburatani; Herbert C Morse; Keiko Ozato; Tomohiko Tamura
Journal:  Blood       Date:  2014-11-14       Impact factor: 22.113

3.  An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.

Authors:  John D Klement; Amy V Paschall; Priscilla S Redd; Mohammed L Ibrahim; Chunwan Lu; Dafeng Yang; Esteban Celis; Scott I Abrams; Keiko Ozato; Kebin Liu
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

Review 4.  Nonclassical patrolling monocyte function in the vasculature.

Authors:  Graham Thomas; Robert Tacke; Catherine C Hedrick; Richard N Hanna
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

5.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

6.  Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.

Authors:  A Sharma; H Yun; N Jyotsana; A Chaturvedi; A Schwarzer; E Yung; C K Lai; F Kuchenbauer; B Argiropoulos; K Görlich; A Ganser; R K Humphries; M Heuser
Journal:  Leukemia       Date:  2014-05-20       Impact factor: 11.528

7.  Epigenetic regulation of cellular and cytomegalovirus genes during myeloid cell development.

Authors:  Xue-Feng Liu; Mary Hummel; Michael Abecassis
Journal:  Intern Med Rev (Wash D C)       Date:  2017-03

8.  Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.

Authors:  Daisuke Kurotaki; Wataru Kawase; Haruka Sasaki; Jun Nakabayashi; Akira Nishiyama; Herbert C Morse; Keiko Ozato; Yutaka Suzuki; Tomohiko Tamura
Journal:  Blood       Date:  2019-02-22       Impact factor: 22.113

9.  Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic cell and monocyte fate.

Authors:  Xiaodi Wu; Carlos G Briseño; Gary E Grajales-Reyes; Malay Haldar; Arifumi Iwata; Nicole M Kretzer; Wumesh Kc; Roxane Tussiwand; Yujiro Higashi; Theresa L Murphy; Kenneth M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

Review 10.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.